Neoleukin Therapeutics

Neoleukin Therapeutics: Develops next-generation immunotherapies for cancer, inflammation and autoimmunity using de novo protein design technology. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to improve tolerability and activity by eliminating the alpha receptor binding interface. NL-201 is currently being evaluated in a Phase 1 clinical trial in patients with relapsed or refractory cancer and the company is expecting interim data in 2022. Cash $164.2M as of June 30, 2021; sufficiently capitalized to fund operations into 2023
Sector/Industry:
Healthcare/Drug Manufacturers
Characteristics:
Based in...
US - Pacific
Clinical Stage
Pre-Clinical Stage
Disease Space
Allergy, Autoimmune, Immuno-Oncology, Infectious Disease, Oncology
Listing
Public, USA
Market Cap
<100MM
Website:
Profiles:
Address:
1616 Eastlake Avenue E
Suit 360
Seattle, WA 98109
United States

Company Participants at Solebury Trout Hamptons CEO Roundtable 2021

  • Jonathan G. Drachman, President/CEO/CFO

Top 10 Holders of Neoleukin Therapeutics, Inc

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Baker Bros. Advisors LP 9.00 3,824,000 4.02 Stakes 5/12/22
Redmile Group LLC 8.16 3,465,435 3.64 13F 3/31/22
Pictet Asset Management SA 6.06 2,574,315 2.70 13F 3/31/22
Millennium Management LLC 5.02 2,132,586 2.24 Stakes 7/18/22
BlackRock Fund Advisors 3.65 1,551,576 1.63 13F 3/31/22
Candriam Belgium SA 3.41 1,448,598 1.52 Funds 4/29/22
Renaissance Technologies LLC 2.99 1,268,969 1.33 13F 3/31/22
Vanguard Group, Inc. (Subfiler) 2.92 1,240,585 1.30 13F 3/31/22
Point72 Asset Management LP (Old) 2.88 1,225,000 1.29 13F 3/31/22
The Vanguard Group, Inc. 2.72 1,155,071 1.21 Funds 6/30/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.